WHO Molecular Detection of RSV EQA 2024

World Health Organization in collaboration with Centers for Disease Control (CDC USA) and UK NEQAS for Microbiology

August 2024

RSV EQA Questionnaire

Please fill in the details below as requested.

UK NEQAS ID (eg. WR9999)*

In which country is your laboratory located?

In which city is your laboratory located?

What is the name of your organisation?*

What is the laboratory name?*

What is the laboratory address?

What is the laboratory name used in GISAID or GenBank for RSV sequences upload (If applicable)?*

Name of RSV Focal Point contact person in the laboratory

Email of RSV Focal Point

What is the name of person completing the questionnaire?

What is the position of person completing the questionnaire?

Are your laboratory enrolled on WHO RSV Surveillance Project? *

No

Yes 1st Pilot Phase

Yes 2nd Phase

Yes Expanded Phase

Has your laboratory reported results in previous rounds of RSV EQA? *

No

Yes since 1st round

Yes since 2nd round

Yes Both rounds

What type of extraction is used in your laboratory? *

Manual

Automatic

Both

What extraction kit have you used? *

QIAamp Viral RNA

NucleoSpin Dx Virus

Magna Pure 96

Other : please specify

What virus detection protocol/kit used?

What virus typing protocol/kit used?

Did you conduct RSV surveillance during 2020? *

Yes

No

If yes, what age groups?

If yes, what was the case definition used?

If yes, were specimens tested for RSV?

Were there any disruptions in inpatient RSV surveillance?

Has your algorithm for testing RSV and influenza changed due to SARS-CoV2 testing?

If yes, describe the changes in the testing algorithm (send testing algorithm flowchart including your Lab ID to organiser@ukneqasparasitology.org.uk)

Has the RSV surveillance experience facilitated the implementation of SARS-CoV2 testing in your laboratory?

When will specimen collection be initiated at sentinel sites?

When will sequencing be initiated in your laboratory?

If your laboratory does not have sequencing capacity or is overwhelmed with other priorities, will your laboratory be willing to ship RSV positive specimens to any of the RSV reference laboratories?

Will your laboratory be willing to upload RSV sequencing data in GISAID?

Please describe any challenges in reporting RSV data to FluMart?

If you have any further comments please fill the box below.

FOR RSV SEQUENCING LABS ONLY

Please provide following information for each specimen.

Specimen 2524

Specimen 2525

Specimen 2526

Library preparation details (2524):

Library preparation details (2525):

Library preparation details (2526):

Sequencing platform used (eg Illumina MiSeq etc) (2524):

Sequencing platform used (eg Illumina MiSeq etc) (2525):

Sequencing platform used (eg Illumina MiSeq etc) (2526):

Target sequencing read depth (2524):

Target sequencing read depth (2525):

Target sequencing read depth (2526):

Reference sequence used (2524):

Reference sequence used (2525):

Reference sequence used (2526):

NGS bioinformatics pipeline used (2524):

NGS bioinformatics pipeline used (2525):

NGS bioinformatics pipeline used (2526):

Any additional comments:

WHO Molecular Detection of RSV EQA 2024

MOST POPULAR

HOME

HELP AND SUPPORT

FOLLOW US